Asset and Liability Management Committee Sample Clauses

Asset and Liability Management Committee. The Asset and Liability Management Committee shall be comprised of five (5) members of which Itaú Parent shall be entitled to appoint three (3) members, and Corp Group Parent shall be entitled to appoint two (2) members.
AutoNDA by SimpleDocs
Asset and Liability Management Committee. The DSBG’s ALCO is accountable to the Executive Committee of the DSBG Group and of the Bank, and oversees the overall management of the balance sheet, liquidity, funding, interest rate risk and market risk of the DSBG Group and of the Bank. It is responsible for formulating business plans affecting lending business, loan mix, treasury investments, deposit taking and capital management. It also plays a key role in the overall risk governance and management of the DSBG Group and the Bank. The DSBG Group’s ALCO meets every week and its regular tasks include review of key business emphasis and development, loan and deposit changes, funding requirement, liquidity, surplus funds investments, capital market dealing, and review of market changes and competition. The DSBG Group’s ALCO also conducts a regular monthly review of overall balance sheet and business performance, including trend analysis and actual positions against limits and targets. The DSBG Group’s ALCO is chaired by the Chief Executive of the DSBG Group, who is also the Chief Executive of the Bank. Members of the ALCO include executive directors of the Bank, heads of most business divisions, risk management and financial control.
Asset and Liability Management Committee. There shall be an asset and liability management committee composed of not less than three directors, appointed by the Chairman of the Board annually or more often. The asset and liability management committee shall have the power, as is lawfully delegated by the board, pursuant to an asset and liability management policy adopted by resolution of the board, to ensure adherence to the investment and liability management policy, to recommend amendments thereto and to exercise authority regarding investments and the management of liabilities. The asset and liability management committee shall keep minutes of its meetings, and such minutes shall be submitted at the next regular meeting of the Board of Directors at which a quorum is present, and any action taken by the board with respect thereto shall be entered in the minutes of the board.
Asset and Liability Management Committee. The Dah Sing Banking Group’s ALCO is accountable to the Executive Committee of the Bank and the Group, and oversees the overall management of the balance sheet, liquidity, funding and market risk of the Group and of the Bank. It is responsible for formulating business plans affecting lending business, loan mix, treasury investments, deposit taking and capital management. It also plays a key role in the overall risk governance and management of the Group and the Bank. The Group’s ALCO meets every week and its regular tasks include review of key business emphasis and development, loan and deposit changes, funding requirement, liquidity, surplus funds investments, capital market dealing, and review of market changes and competition. The Group’s ALCO also conducts a regular monthly review of overall balance sheet and business performance, including trend analysis and actual positions against limits and targets. The Group’s ALCO is chaired by the Chief Executive of the Group, who is also the Chief Executive of the Bank. Members of the ALCO include all executive directors of the Bank, heads of most business divisions, risk management and financial control.

Related to Asset and Liability Management Committee

  • Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.

  • Management Committee The Members shall act collectively through meetings as a "committee of the whole," which is hereby named the "Management Committee." The Management Committee shall conduct its affairs in accordance with the following provisions and the other provisions of this Agreement:

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Advisory Committee The Settling State shall designate an Opioid Settlement Remediation Advisory Committee (the “Advisory Committee”) to provide input and recommendations regarding remediation spending from that Settling State’s Abatement Accounts Fund. A Settling State may elect to use an existing advisory committee or similar entity (created outside of a State-Subdivision Agreement or Allocation Statute); provided, however, the Advisory Committee or similar entity shall meet the following requirements:

Time is Money Join Law Insider Premium to draft better contracts faster.